
|Articles|January 1, 2005
It's crunch time: Tips to make up for lost dollars
The year 2005 will portend a significant decrease in income for nearly every American urologist. Most will be impacted by Medicare's slashing the reimbursement for LHRH agonists and certain other drugs administered in the office. Solo practitioners can anticipate annual losses of income in the thousands of dollars, and larger group practices can expect over a $1 million shortfall this year.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
5











